• 1
    Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 2001;276:7811-7819.
  • 2
    Finberg KE. Unraveling mechanisms regulating systemic iron homeostasis. Hematology Am Soc Hematol Educ Program 2011;2011:532-537.
  • 3
    Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004;306:2090-2093.
  • 4
    Nicolas G, Bennoun M, Porteu A, Mativet S, Beaumont C, Grandchamp B, et al. Severe iron deficiency anemia in transgenic mice expressing liver hepcidin. Proc Natl Acad Sci U S A 2002;99:4596-4601.
  • 5
    Roetto A, Papanikolaou G, Politou M, Alberti F, Girelli D, Christakis J, et al. Mutant antimicrobial peptide hepcidin is associated with severe juvenile hemochromatosis. Nat Genet 2003;33:21-22.
  • 6
    Kautz L, Meynard D, Monnier A, Darnaud V, Bouvet R, Wang RH, et al. Iron regulates phosphorylation of Smad1/5/8 and gene expression of Bmp6, Smad7, Id1, and Atoh8 in the mouse liver. Blood 2008;112:1503-1509.
  • 7
    Andriopoulos B, Jr., Corradini E, Xia Y, Faasse SA, Chen S, et al. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet 2009;41:482-487.
  • 8
    Meynard D, Kautz L, Darnaud V, Canonne-Hergaux F, Coppin H, Roth MP. Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet 2009;41:478-481.
  • 9
    Huang FW, Pinkus JL, Pinkus GS, Fleming MD, Andrews NC. A mouse model of juvenile hemochromatosis. J Clin Invest 2005;115:2187-2191.
  • 10
    Niederkofler V, Salie R, Arber S. Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. J Clin Invest 2005;115:2180-2186.
  • 11
    Krijt J, Niederkofler V, Salie R, Sefc L, Pelichovska T, Vokurka M, et al. Effect of phlebotomy on hepcidin expression in hemojuvelin-mutant mice. Blood Cells Mol Dis 2007;39:92-95.
  • 12
    Harrison-Findik DD. Gender-related variations in iron metabolism and liver diseases. World J Hepatol 2010;2:302-310.
  • 13
    Hod EA, Francis RO, Spitalnik SL, Winters A, Cooke KS, Sasu BJ.Validation and preclinical correlation of a new sandwich ELISA for measuring murine hepcidin. In: 54th ASH Annual Meeting and Exposition. Atlanta, GA; 2012.
  • 14
    Torrance JD, Bothwell TH. Tissue iron stores. In: Cook JD, editor. Iron. Methods in hematology. Vol.1. New York: Churchill Livingstone; 1980. p 90-115.
  • 15
    Courselaud B, Troadec MB, Fruchon S, Ilyin G, Borot N, Leroyer P, Coppin H, et al. Strain and gender modulate hepatic hepcidin 1 and 2 mRNA expression in mice. Blood Cells Mol Dis 2004;32:283-289.
  • 16
    Krijt J, Cmejla R, Sykora V, Vokurka M, Vyoral D, Necas E. Different expression pattern of hepcidin genes in the liver and pancreas of C57BL/6N and DBA/2N mice. J Hepatol 2004;40:891-896.
  • 17
    Guo W, Bachman E, Li M, Roy CN, Blusztajn J, Wong S, et al. Testosterone administration inhibits hepcidin transcription and is associated with increased iron incorporation into red blood cells. Aging Cell 2013;12:280-291.
  • 18
    Krijt J, Jonasova A, Neuwirtova R, Necas E. Effect of erythropoietin on hepcidin expression in hemojuvelin-mutant mice. Blood Cells Mol Dis 2010;44:257-261.
  • 19
    Gordon AS, Mirand EA, Wenig J, Katz R, Zanjani ED. Androgen actions on erythropoiesis. Ann N Y Acad Sci 1968;149:318-335.
  • 20
    Teruel JL, Cano T, Marcen R, Villafruela JJ, Rivera M, Fernandez-Juarez G, et al. Decrease in the haemoglobin level in haemodialysis patients undergoing antiandrogen therapy. Nephrol Dial Transplant 1997;12:1262-1263.
  • 21
    Goodnough JB, Ramos E, Nemeth E, Ganz T. Inhibition of hepcidin transcription by growth factors. Hepatology 2012;56:291-299.
  • 22
    Noguchi S, Ohba Y, Oka T. Pretranslational enhancement of epidermal growth factor receptor by direct effect of testosterone in mouse liver. Endocrinology 1991;128:2141-2148.
  • 23
    Scoccia B, Kovar P, Benveniste R. Gonadal and adrenal effects on hepatic epidermal growth factor receptor expression in a murine model. Endocrinology 1991;129:3240-3246.
  • 24
    Hadziahmetovic M, Song Y, Wolkow N, Iacovelli J, Kautz L, Roth MP, et al. Bmp6 regulates retinal iron homeostasis and has altered expression in age-related macular degeneration. Am J Pathol 2011;179:335-348.
  • 25
    Jenkitkasemwong S, Wang CY, Mackenzie B, Knutson MD. Physiologic implications of metal-ion transport by ZIP14 and ZIP8. Biometals 2012;25:643-655.
  • 26
    Nam H, Wang CY, Zhang L, Zhang W, Hojyo S, Fukada T, et al. ZIP14 and DMT1 in the liver, pancreas, and heart are differentially regulated by iron deficiency and overload: implications for tissue iron uptake in iron-related disorders. Haematologica 2013;98:1049-1057.
  • 27
    Noetzli LJ, Papudesi J, Coates TD, Wood JC. Pancreatic iron loading predicts cardiac iron loading in thalassemia major. Blood 2009;114:4021-4026.
  • 28
    Shahani S, Braga-Basaria M, Maggio M, Basaria S. Androgens and erythropoiesis: past and present. J Endocrinol Invest 2009;32:704-716.
  • 29
    Calof OM, Singh AB, Lee ML, Kenny AM, Urban RJ, Tenover JL, et al. Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci 2005;60:1451-1457.
  • 30
    Coviello AD, Kaplan B, Lakshman KM, Chen T, Singh AB, Bhasin S. Effects of graded doses of testosterone on erythropoiesis in healthy young and older men. J Clin Endocrinol Metab 2008;93:914-919.
  • 31
    Kim SW, Hwang JH, Cheon JM, Park NS, Park SE, Park SJ, et al. Direct and indirect effects of androgens on survival of hematopoietic progenitor cells in vitro. J Korean Med Sci 2005;20:409-416.
  • 32
    Bachman E, Feng R, Travison T, Li M, Olbina G, Ostland V, et al. Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis. J Clin Endocrinol Metab 2010;95:4743-4747.
  • 33
    Escobar-Morreale HF. Iron metabolism and the polycystic ovary syndrome. Trends Endocrinol Metab 2012;23:509-515.
  • 34
    Luque-Ramirez M, Alvarez-Blasco F, Alpanes M, Escobar-Morreale HF. Role of decreased circulating hepcidin concentrations in the iron excess of women with the polycystic ovary syndrome. J Clin Endocrinol Metab 2011;96:846-852.
  • 35
    Campostrini N, Traglia M, Martinelli N, Corbella M, Cocca M, Manna D, et al. Serum levels of the hepcidin-20 isoform in a large general population: the Val Borbera study. J Proteomics 2012;76(Spec No):28-35.
  • 36
    Papanikolaou G, Samuels ME, Ludwig EH, MacDonald ML, Franchini PL, Dube MP, et al. Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 2004;36:77-82.
  • 37
    Camaschella C, Roetto A, De Gobbi M. Juvenile hemochromatosis. Semin Hematol 2002;39:242-248.
  • 38
    Harrison-Findik DD, Schafer D, Klein E, Timchenko NA, Kulaksiz H, Clemens D, et al. Alcohol metabolism-mediated oxidative stress down-regulates hepcidin transcription and leads to increased duodenal iron transporter expression. J Biol Chem 2006;281:22974-22982.